新文章：伊维菌素、芬苯达唑、MCP、CBD 患者证言 - 一位73岁佛罗里达女性患肌层浸润性膀胱癌，6个月后报告：癌症痊愈！

另一位佛罗里达伊维菌素成功案例 😃

故事：
73岁佛罗里达女性患肌层浸润性膀胱癌

2026年3月她开始服用：

伊维菌素 60mg/天
芬苯达唑 1500mg/天
MCP 15g/天
CBD 油 100mg/天

肿瘤医生：恩福妥单抗和帕博利珠单抗

6个月后结果：无证据疾病（NED）

另一个前沿再利用药物与传统疗法（PADCEV & KEYTRUDA）治疗协同效应的例子。

膀胱癌令人沮丧，因为它们常常复发 - 复发率非常高。

添加再利用药物的目标是阻止这种癌症复发。这可以用于：

膀胱癌
皮肤癌
脑癌

我在全球最大的“尝试权”研究项目中，用伊维菌素、甲苯咪唑和芬苯达唑帮助了超过9000名癌症患者。

而这仅仅是个开始……😉

NEW ARTICLE: IVERMECTIN, FENBENDAZOLE, MCP, CBD Testimonial - 73 year old Florida woman with muscle invasive Bladder Cancer reports after 6 months: cancer free!

Another Florida Ivermectin success story 😃

STORY:
73 year old Florida woman with muscle invasive Bladder Cancer

In March 2026 she started:

Ivermectin 60mg/day
Fenbendazole 1500mg/day
MCP 15g/day
CBD Oil 100mg/day

Oncologist: Enfortumab vedotin and pembrolizumab

Results after 6 months: NED

Another example of treatment synergy between cutting edge repurposed drugs and conventional therapy (PADCEV & KEYTRUDA).

Bladder cancers are frustrating because they often come back - recurrence rate is very high.

The goal of adding repurposed drugs is to stop this cancer from coming back. This can be done for:

Bladder Cancers
Skin Cancers
Brain Cancers

I have helped over 9000 Cancer patients with Ivermectin, Mebendazole and Fenbendazole in the largest "Right to Try" Research Project in the world.

And that was just the start...😉 @MakisMedicine